Perioperative Lactate Kinetics in Patient Undergoing Major Liver Surgery
Evaluation of Lactate Levels in as a Risk Factor for Posthepatectomy Liver Failure
1 other identifier
observational
55
1 country
1
Brief Summary
Major liver surgery is associated with increased incidence of perioperative complications and increased mortality if these are not addressed quickly in a high dependency intensive care unit. Of these, posthepatectomy liver failure (PHLF) represents one of the most important cause of postoperative unfavourable outcome. The present study investigates the correlation between lactate levels and PHLF. Lactate levels were collected at six specific timepoints: preoperative, pre-dissection phase, post-dissection phase, end of surgery and 24-hours and 48-hours in the postoperative period.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jan 2017
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2019
CompletedFirst Submitted
Initial submission to the registry
August 10, 2020
CompletedFirst Posted
Study publicly available on registry
August 13, 2020
CompletedAugust 13, 2020
August 1, 2020
3 years
August 10, 2020
August 12, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
lactate levels (mmol/L) in patients with PHLF
correlation of lactate levels with the diagnosis of PHLF
early postoperative period (48 hours)
Secondary Outcomes (1)
mortality
30 days mortality
Study Arms (1)
major liver surgery
Patients undergoing major liver surgery
Interventions
Eligibility Criteria
all patients undergoing major liver failure in our institution
You may qualify if:
- patients undergoing major liver surgery for primary or secondary tumours
You may not qualify if:
- unsigned patient consent
- death within 24 hours
- need for perioperative renal replacement therapy
- underlying liver disease (e.g. liver cirrhosis)
- other causes of raised lactate levels (e.g. shock)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Fundeni Clinical Institute
Bucharest, 022328, Romania
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Dana Tomescu, Prof
Fundeni Clinical Institute
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinical Professor
Study Record Dates
First Submitted
August 10, 2020
First Posted
August 13, 2020
Study Start
January 1, 2017
Primary Completion
December 31, 2019
Study Completion
December 31, 2019
Last Updated
August 13, 2020
Record last verified: 2020-08
Data Sharing
- IPD Sharing
- Will not share